Proteome and Metabolome Profiling of Anticoagulant Disorders Induced by Familial Protein S Deficiency by Caiping Zhang (6745976)

“…Furthermore, 9 differential proteins correlated significantly with protein S, comprising A2M, AGT, APOE, FGG, GPLD1, IGHV1–69, CFHR5, CPN2, and CA1. …”

Proteome and Metabolome Profiling of Anticoagulant Disorders Induced by Familial Protein S Deficiency by Caiping Zhang (6745976)

“…Furthermore, 9 differential proteins correlated significantly with protein S, comprising A2M, AGT, APOE, FGG, GPLD1, IGHV1–69, CFHR5, CPN2, and CA1. …”

Proteome and Metabolome Profiling of Anticoagulant Disorders Induced by Familial Protein S Deficiency by Caiping Zhang (6745976)

“…Furthermore, 9 differential proteins correlated significantly with protein S, comprising A2M, AGT, APOE, FGG, GPLD1, IGHV1–69, CFHR5, CPN2, and CA1. …”

Proteome and Metabolome Profiling of Anticoagulant Disorders Induced by Familial Protein S Deficiency by Caiping Zhang (6745976)

“…Furthermore, 9 differential proteins correlated significantly with protein S, comprising A2M, AGT, APOE, FGG, GPLD1, IGHV1–69, CFHR5, CPN2, and CA1. …”

Proteome and Metabolome Profiling of Anticoagulant Disorders Induced by Familial Protein S Deficiency by Caiping Zhang (6745976)

“…Furthermore, 9 differential proteins correlated significantly with protein S, comprising A2M, AGT, APOE, FGG, GPLD1, IGHV1–69, CFHR5, CPN2, and CA1. …”

PAM16 correlation with N-MYC. by Zahra Motahari (6814013)

Expression of MAGMAS in medulloblastoma. by Zahra Motahari (6814013)

Chemical properties of the soil. by Dominika Radzikowska-Kujawska (14439076)

“…In the control, CO₂ assimilation was practically inhibited due to drought (98% drop), while in the plants in which the Trichoderma preparation was used together with half dose of NPK and manure, there was only a slight decrease (1% and 13% respectively). A greatest, significant improvement in the DM of roots under drought was noted in plants in which the Pisum forecrop was applied together with NPK and manure (230% and 168% respectively). …”

Change in the ERCC1 secretion level in plasma(pg/ml). by Hao Deng (409186)

MAGMAS inhibition on mitochondrial activity in medulloblastoma cells. by Zahra Motahari (6814013)

MAGMAS inhibition induces medulloblastoma cell death. by Zahra Motahari (6814013)

BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

“…(C) Compared to control, BT9 treatment significantly decreased the number of invading DAOY and D425 cells (****p < 0.0001, BT9 vs vehicle control, n = 6). 4x magnification.…”

The effect of MAGMAS inhibition on mitochondrial respiration and acidification rate in D425 cells. by Zahra Motahari (6814013)

Metals concentrations in selected coal samples. by Ruchika Kishor Jain (19704102)

“…After BAI-RCD treatment, both cell lines showed a decrease in antioxidant stress measures (SOD, CAT, and GSH) and a significant (<i>p</i> < 0.001) increase in oxidative stress parameters (NADPH, MPO, LPO, and PC). …”

Effect of follicular fluid (FF) supplementation during the maturation period on cumulus cell expansion. by Verónica M. Negrón-Pérez (20691412)

MAGMAS inhibition reduces DAOY cells migration. by Zahra Motahari (6814013)

S1 Data - by Hao Deng (409186)

“…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”

Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

“…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”

BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. by Zahra Motahari (6814013)

Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... by Vidya G. Bettada (22208808)

“…Beginning from day 28, when the solid tumors are of ~100mm³ size, control and experimental mice were administered with drugs every other day for 18 days (total duration 46 days); on day 46, the mice were sacrificed and blood, vital organs and tumors were harvested for further analysis (b) Administration of STZ increased fasting blood sugar in mice: In order to establish hyperglycaemic state, mice were administered with low-dose STZ as detailed in methods section and blood sugar content determined using Morepen glucose monitoring strips. The data showed a significant increase in fasting blood glucose (FBG) beginning from day 6. …”